Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CLGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CLGN

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Collplant Biotechnologies Ltd

CLGN
Current price
1.44 USD +0.03 USD (+2.13%)
Last closed 1.41 USD
ISIN IL0004960188
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 17 929 560 USD
Yield for 12 month -71.54 %
1Y
3Y
5Y
10Y
15Y
CLGN
21.11.2021 - 28.11.2021

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company's products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. It offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound healing flowable gel for the treatment of chronic and acute wounds. The company also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. It has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel. Address: Weizmann Science Park, Rehovot, Israel, 7670104

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.00 USD

P/E Ratio

Dividend Yield

Financials CLGN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CLGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+515 000 USD

Last Year

+10 959 000 USD

Current Quarter

+2 055 000 USD

Last Quarter

+164 000 USD

Current Year

-1 110 000 USD

Last Year

+8 968 000 USD

Current Quarter

+1 867 000 USD

Last Quarter

-108 000 USD
EBITDA -13 568 000 USD
Operating Margin TTM -80.20 %
Price to Earnings
Return On Assets TTM -38.34 %
PEG Ratio
Return On Equity TTM -75.27 %
Wall Street Target Price 12.00 USD
Revenue TTM 2 472 000 USD
Book Value 1.08 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 1 996.90 %
Dividend Yield
Gross Profit TTM 1 204 000 USD
Earnings per share -1.21 USD
Diluted Eps TTM -1.21 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation CLGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 15.55
Enterprise Value Revenue 3.97
Price Sales TTM 7.25
Enterprise Value EBITDA -5.97
Price Book MRQ 1.43

Technical Indicators CLGN

For 52 Weeks

1.31 USD 5.45 USD
50 Day MA 1.86 USD
Shares Short Prior Month 79 263
200 Day MA 3.22 USD
Short Ratio 0.36
Shares Short 86 603
Short Percent 0.90 %